ScoutQuest2 Nov 2026
Mold-Tek Packaging533080Quarterly results

Mold-Tek Packaging H1 FY27 presentation: Q2 revenue up 31% to Rs. 274.23 Cr, PAT up 36%

Q2 FY27 revenue up 31% to Rs. 274.23 Cr and PAT up 36% to Rs. 21.07 Cr, but EBITDA margin slipped 13 bps to 18.70%.

By ScoutQuest · · 1 min read

574.68 (INR Cr)
Q2 FY27274.23 (INR Cr)H1 FY27574.68 (INR Cr)
Revenue: 274.23 (INR Cr) (Q2 FY27) and 574.68 (INR Cr) (H1 FY27).
Q2 FY27 Revenue
Rs. 274.23 Cr, up 31% YoY
Q2 FY27 PAT
Rs. 21.07 Cr, up 36% YoY
Q2 FY27 EBITDA Margin
18.70%, down 13 bps
Period
Q2 FY27 and H1 FY27
Positioning
Mold-Tek presents itself as one of India's leading rigid plastic packaging players, with 10 manufacturing units, 10 ISO certified plants, over 66,900 TPA installed injection moulding capacity and a claim to pioneering in-mould labelling in

📉 Q2 FY27 revenue rose 31% year on year to Rs. 274.23 Cr, EBITDA 30% to Rs. 51.27 Cr and PAT 36% to Rs. 21.07 Cr on volume of 11,028 MT, but EBITDA margin slipped 13 bps to 18.70% and revenue was down 9% from Q1 FY27.

📈 For H1 FY27 the presentation prints revenue of Rs. 574.68 Cr (+28%), EBITDA of Rs. 107.70 Cr (+24%) and PAT of Rs. 46.64 Cr (+23%), with H1 EBITDA margin at 18.74%, 55 bps below the 19.29% of a year earlier; FY26 full-year revenue was Rs. 886.61 Cr and PAT Rs. 72.87 Cr.

📈 Segment revenue for Q2 FY27 is printed at Rs.116Cr. for Paints, Rs.13.63Cr. for Pharma, Rs.59Cr. for Food, Rs.48Cr. for Q Pack and Rs.36Cr. for Lubes; the chart marks Lubes down 12% with the only falling arrow, while Pharma and Food carry 26% and 35% growth markers.

🏭 Management says 5 plants were consolidated into 2 locations to translate into better EBIDTA growth, label making was brought under one roof with offset printing and AI inspection lifting capacity by 50%, and an understanding was signed with UK-based Vibe Generation LLP to develop and commercialise IP-based precision caps and closures.

More numbers
  • Revenue, Q2 FY27274.23 (INR Cr)
  • Profit after tax, Q2 FY2721.07 (INR Cr)
  • EBITDA, Q2 FY2751.27 (INR Cr)
  • EBITDA margin, Q2 FY2718.70%
  • Volume, Q2 FY2711028 (MT)
  • Revenue, H1 FY27574.68 (INR Cr)
  • Profit after tax, H1 FY2746.64 (INR Cr)
  • Pharma segment revenue, Q2 FY27Rs.13.63Cr.
  • Food segment revenue, Q2 FY27Rs.59Cr.
  • Paints segment revenue, Q2 FY27Rs.116Cr.
  • Lubes segment revenue, Q2 FY27Rs.36Cr.
Source: BSE · 2 Nov 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev